Profile for World Intellectual Property Organization (WIPO) Patent: 2018129556
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2018129556
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 30, 2029 | Ardelyx Inc | IBSRELA | tenapanor hydrochloride |
| ⤷ Start Trial | Dec 30, 2029 | Ardelyx Inc | XPHOZAH | tenapanor hydrochloride |
| ⤷ Start Trial | Aug 1, 2033 | Ardelyx Inc | IBSRELA | tenapanor hydrochloride |
| ⤷ Start Trial | Aug 1, 2033 | Ardelyx Inc | XPHOZAH | tenapanor hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
